The global telepathology market was valued at USD 22.58 billion in 2024 and is expected to reach USD 69.99 billion by 2032, growing at a compound annual growth rate (CAGR) of 16.5% during the forecast period. In 2025, the market is projected to reach USD 24.07 billion. North America led the telepathology market in 2024, accounting for a dominant share of 46.89%.

The telepathology market is experiencing steady growth, fueled by advancements in digital imaging technologies, increasing demand for remote diagnostic solutions, and a global shortage of pathologists. Telepathology enables the transmission of high-resolution pathology images over telecommunication networks, allowing for remote consultations, second opinions, and faster diagnostic turnaround times. This technology is particularly valuable in rural and underserved areas where access to specialized pathology services is limited. The integration of artificial intelligence and cloud-based platforms is further enhancing diagnostic accuracy and workflow efficiency. As healthcare systems continue to prioritize digital transformation and telehealth adoption, the telepathology market is expected to expand significantly in the coming years.

Continue reading for more details: https://www.fortunebusinessinsights.com/telepathology-market-112685

Market Segmentation

• By component, the telepathology market includes hardware (scanners, microscopes), software, and services.
• Based on modality, the telepathology market is segmented into static, real‑time (dynamic), and hybrid systems.
• For application, the telepathology market serves oncology diagnostics, histopathology, cytopathology, intraoperative consultations, and education.
• By end‑user, the telepathology market caters to hospitals, diagnostic labs, academic/research institutions, and telehealth providers.
• The telepathology market also segments based on deployment: on‑premises and cloud‑based solutions.

List Of Key Telepathology Companies Profiled:

• Krsnaa Diagnostics Ltd. (India)
• OptraScan (U.S.)
• CompuMed, Inc. (U.S.)
• Diagnostic Instruments, Inc. (U.S.)
• UCLA Health (U.S.)
• Grundium Ltd (Finland)
• Leica Biosystems Nussloch GmbH (Germany)
• Medica Reporting Ltd. (U.K.)
• Specialist Direct LLC. (U.S.)